The value of molecular stratification for CEBPA (DM) and NPM1 (MUT) FLT3 (WT) genotypes in older patients with acute myeloid leukaemia

Older adult patients (≥60 years) with acute myeloid leukaemia (AML) are generally considered to be poor‐risk and there is limited information available regarding risk stratification based on molecular characterization in this age group, particularly for the double‐mutant CEBPA (CEBPA (DM)) genotype....

Descripción completa

Detalles Bibliográficos
Autores principales: Dickson, Glenda J., Bustraan, Sophia, Hills, Robert K., Ali, Akbar, Goldstone, Anthony H., Burnett, Alan K., Linch, David C., Gale, Rosemary E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855634/
https://www.ncbi.nlm.nih.gov/pubmed/26847745
http://dx.doi.org/10.1111/bjh.13873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855634/
https://www.ncbi.nlm.nih.gov/pubmed/26847745
http://dx.doi.org/10.1111/bjh.13873

Ejemplares similares